OURCROWD (INVESTMENT IN SURGICAL THEATRE) L.P. — Form D
OURCROWD (INVESTMENT IN SURGICAL THEATRE) L.P. of JERUSALEM, L3, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2023-01-24. The offering totals $500K, of which $70K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2023-01-24
- Form: D
- Accession: 0001580728-23-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c, 3C, 3C.1
- Total offering: $500K
- Amount sold: $70K
- Remaining: $430K
- Minimum investment: $10K
- Investors: 4
- Date of first sale: 2023-01-17
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-471640
Issuer
- Name: OURCROWD (INVESTMENT IN SURGICAL THEATRE) L.P.
- CIK: 0001580728
- Entity type: Limited Partnership
- Jurisdiction: VIRGIN ISLANDS, BRITISH
- Incorporated: 2013
- Address: 28 DERECH HEBRON, JERUSALEM, L3, 9108001
- Phone: 972-2-636-9303
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Jonathan Medved | Director | Jerusalem, L3 |
| Caleb Chill | Executive Officer | Jerusalem, L3 |
| Robert Citron | Executive Officer | Jerusalem, L3 |
| Andrew Kaye | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Executive Officer | Jerusalem, L3 |
| Jonathan Medved | Promoter | Jerusalem, L3 |
| Jay Kalish | Executive Officer | Jerusalem, L3 |
| Steven Blumgart | Director | Jerusalem, L3 |
| Steven Blumgart | Executive Officer | Jerusalem, L3 |
| Steven Blumgart | Promoter | Jerusalem, L3 |
Other filings by this issuer (6)
More